Evangeline Mose • UCSD Profiles (original) (raw)
- Redirecting cytomegalovirus immunity against pancreas cancer for immunotherapy. J Immunother Cancer. 2026 Feb 04; 14(2). Marrocco R, Patel J, Medari R, Salu P, Lucero-Meza E, Maia C, Brunel S, Martsinkovskiy A, Sun S, Gulay K, Jaljuli M, Mose E, Lowy A, Benedict C, Hurtado de Mendoza T. PMID: 41638871; PMCID: PMC12927352.
View in: PubMed Mentions: Fields:
Translation:HumansAnimalsCells - Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. Proc Natl Acad Sci U S A. 2026 Jan 27; 123(4):e2511733123. Antonucci L, Watari K, Feng Y, Qi J, Zhu M, Wang T, Ng I, Vucic EA, Riahi I, Huang L, Hosseini M, Mose E, French R, Weitz J, Bar-Sagi D, Dawson DW, Sun B, Tiriac H, Xu J, Xu S, Lowy AM, Karin M. PMID: 41564125; PMCID: PMC12849708.
View in: PubMed Mentions: Fields:
Translation:HumansAnimalsCells - MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Cancer Res. 2025 Mar 14; 85(6):1049-1063. Garg B, Khan S, Courelli AS, Panneerpandian P, Sheik Pran Babu D, Mose ES, Gulay KCM, Sharma S, Sood D, Wenzel AT, Martsinkovskiy A, Rajbhandari N, Patel J, Jaquish D, Esparza E, Jaque K, Aggarwal N, Lambies G, D'Ippolito A, Austgen K, Johnston B, Orlando DA, Jang GH, Gallinger S, Goodfellow E, Brodt P, Commisso C, Tamayo P, Mesirov JP, Tiriac H, Lowy AM. PMID: 39745352; PMCID: PMC11907191.
View in: PubMed Mentions: 3 Fields:
Translation:HumansAnimalsCells - MICAL2 Is a Super Enhancer Associated Gene that Promotes Pancreatic Cancer Growth and Metastasis. bioRxiv. 2024 Jun 30. Garg B, Khan S, Babu DS, Mose E, Gulay K, Sharma S, Sood D, Wenzel AT, Martsinkovskiy A, Patel J, Jaquish D, Lambies G, D'Ippolito A, Austgen K, Johnston B, Orlando D, Jang GH, Gallinger S, Goodfellow E, Brodt P, Commisso C, Tamayo P, Mesirov JP, Tiriac H, Lowy AM. PMID: 38979336; PMCID: PMC11230455.
View in: PubMed Mentions: - Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma. Cancer Res. 2023 09 15; 83(18):3001-3012. Gulay KCM, Zhang X, Pantazopoulou V, Patel J, Esparza E, Pran Babu DS, Ogawa S, Weitz J, Ng I, Mose ES, Pu M, Engle DD, Lowy AM, Tiriac H. PMID: 37378556; PMCID: PMC10502451.
View in: PubMed Mentions: 42 Fields:
Translation:AnimalsCells - Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker. bioRxiv. 2023 May 24. Suzuki K, Kunisada Y, Miyamura N, Eikawa S, Hurtado de Mendoza T, Mose ES, Lu C, Kuroda Y, Ruoslahti E, Lowy AM, Sugahara KN. PMID: 37292693; PMCID: PMC10245898.
View in: PubMed Mentions: - Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation. Nat Cell Biol. 2023 02; 25(2):309-322. Wu C, Rakhshandehroo T, Wettersten HI, Campos A, von Schalscha T, Jain S, Yu Z, Tan J, Mose E, Childers BG, Lowy AM, Weis SM, Cheresh DA. PMID: 36646789; PMCID: PMC10280815.
View in: PubMed Mentions: 19 Fields:
Translation:HumansCells - Palbociclib as a Novel Therapy for Low-Grade Mucinous Carcinomatosis Peritonei of Appendiceal Origin. JCO Precis Oncol. 2021 11; 5:1069-1072. Childers BG, Sood D, Patel R, Mose ES, Hosseini M, Kato S, Baumgartner JM, Lowy AM. PMID: 34994628.
View in: PubMed Mentions: 2 Fields:
Translation:Humans - Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis. Cancer Cell. 2021 05 10; 39(5):678-693.e11. Su H, Yang F, Fu R, Li X, French R, Mose E, Pu X, Trinh B, Kumar A, Liu J, Antonucci L, Todoric J, Liu Y, Hu Y, Diaz-Meco MT, Moscat J, Metallo CM, Lowy AM, Sun B, Karin M. PMID: 33740421; PMCID: PMC8119368.
View in: PubMed Mentions: 103 Fields:
Translation:AnimalsCells - Tumor-penetrating therapy for β5 integrin-rich pancreas cancer. Nat Commun. 2021 03 09; 12(1):1541. Hurtado de Mendoza T, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, Suzuki K, Miyamura N, Teesalu T, Ruoslahti E, Lowy AM, Sugahara KN. PMID: 33750829; PMCID: PMC7943581.
View in: PubMed Mentions: 42 Fields:
Translation:HumansAnimalsCells - A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer. Clin Cancer Res. 2021 04 01; 27(7):2100-2110. Cazes A, Betancourt O, Esparza E, Mose ES, Jaquish D, Wong E, Wascher AA, Tiriac H, Gymnopoulos M, Lowy AM. PMID: 33451980.
View in: PubMed Mentions: 17 Fields:
Translation:HumansAnimalsCells - MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. Oncogene. 2019 07; 38(28):5599-5611. Babicky ML, Harper MM, Chakedis J, Cazes A, Mose ES, Jaquish DV, French RP, Childers B, Alakus H, Schmid MC, Foubert P, Miyamoto J, Holman PJ, Walterscheid ZJ, Tang CM, Varki N, Sicklick JK, Messer K, Varner JA, Waltz SE, Lowy AM. PMID: 30967626; PMCID: PMC6625868.
View in: PubMed Mentions: 23 Fields:
Translation:HumansAnimalsCells - Inhibition of invasive pancreatic cancer: restoring cell apoptosis by activating mitochondrial p53. Am J Cancer Res. 2019; 9(2):390-405. Cheng J, Okolotowicz KJ, Ryan D, Mose E, Lowy AM, Cashman JR. PMID: 30906636; PMCID: PMC6405982.
View in: PubMed Mentions: 9 - Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics. Oncotarget. 2016 Jul 19; 7(29):45959-45975. Chakedis J, French R, Babicky M, Jaquish D, Mose E, Cheng P, Holman P, Howard H, Miyamoto J, Porras P, Walterscheid Z, Schultz-Fademrecht C, Esdar C, Schadt O, Eickhoff J, Lowy AM. PMID: 27323855; PMCID: PMC5216774.
View in: PubMed Mentions: 17 Fields:
Translation:HumansAnimalsCells - Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression. Cancer Discov. 2016 08; 6(8):870-85. Kaneda MM, Cappello P, Nguyen AV, Ralainirina N, Hardamon CR, Foubert P, Schmid MC, Sun P, Mose E, Bouvet M, Lowy AM, Valasek MA, Sasik R, Novelli F, Hirsch E, Varner JA. PMID: 27179037; PMCID: PMC5091937.
View in: PubMed Mentions: 182 Fields:
Translation:HumansAnimalsCells - Correction: Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. 2014; 6(7):53. Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O. PMID: 25228923; PMCID: PMC4165363.
View in: PubMed Mentions: 2 Fields: - Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. 2014; 6(5):43. Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O. PMID: 24944587; PMCID: PMC4062050.
View in: PubMed Mentions: 55 Fields: - Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor. J Transl Med. 2014 Feb 10; 12:41. Sicklick JK, Leonard SY, Babicky ML, Tang CM, Mose ES, French RP, Jaquish DV, Hoh CK, Peterson M, Schwab R, Lowy AM. PMID: 24507750; PMCID: PMC3930355.
View in: PubMed Mentions: 19 Fields:
Translation:HumansAnimals - A dual-color genetically engineered mouse model for multispectral imaging of the pancreatic microenvironment. Pancreas. 2013 Aug; 42(6):952-8. Snyder CS, Harrington AR, Kaushal S, Mose E, Lowy AM, Hoffman RM, Bouvet M. PMID: 23648841; PMCID: PMC3713119.
View in: PubMed Mentions: 8 Fields:
Translation:Animals - KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer Res. 2012 May 15; 72(10):2554-64. Kelber JA, Reno T, Kaushal S, Metildi C, Wright T, Stoletov K, Weems JM, Park FD, Mose E, Wang Y, Hoffman RM, Lowy AM, Bouvet M, Klemke RL. PMID: 22589274; PMCID: PMC3366503.
View in: PubMed Mentions: 72 Fields:
Translation:HumansAnimalsCells - The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome. Int J Cancer. 2012 Oct 15; 131(8):1744-54. Yu PT, Babicky M, Jaquish D, French R, Marayuma K, Mose E, Niessen S, Hoover H, Shields D, Cheresh D, Cravatt BF, Lowy AM. PMID: 22275185; PMCID: PMC3424378.
View in: PubMed Mentions: 32 Fields:
Translation:HumansCells - Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. Cancer Res. 2010 Feb 01; 70(3):1130-40. Logan-Collins J, Thomas RM, Yu P, Jaquish D, Mose E, French R, Stuart W, McClaine R, Aronow B, Hoffman RM, Waltz SE, Lowy AM. PMID: 20103639; PMCID: PMC2943733.
View in: PubMed Mentions: 58 Fields:
Translation:HumansAnimalsCells - Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation. 2009 Dec; 78(5):283-91. Montel V, Suzuki M, Galloy C, Mose ES, Tarin D. PMID: 19699574.
View in: PubMed Mentions: 22 Fields:
Translation:HumansCells - Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. Am J Pathol. 2007 Aug; 171(2):682-92. Suzuki M, Mose E, Galloy C, Tarin D. PMID: 17620367; PMCID: PMC1934534.
View in: PubMed Mentions: 12 Fields:
Translation:HumansAnimalsCells - Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am J Pathol. 2006 Aug; 169(2):673-81. Suzuki M, Mose ES, Montel V, Tarin D. PMID: 16877365; PMCID: PMC1698784.
View in: PubMed Mentions: 55 Fields:
Translation:HumansAnimalsCells - Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int J Cancer. 2006 Jul 15; 119(2):251-63. Montel V, Mose ES, Tarin D. PMID: 16482564.
View in: PubMed Mentions: 29 Fields:
Translation:HumansAnimalsCells - Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Pathol. 2005 May; 166(5):1565-79. Montel V, Huang TY, Mose E, Pestonjamasp K, Tarin D. PMID: 15855655; PMCID: PMC1606408.
View in: PubMed Mentions: 47 Fields:
Translation:HumansAnimals - Tumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenografts. Differentiation. 2005 Mar; 73(2-3):88-98. Montel V, Pestonjamasp K, Mose E, Tarin D. PMID: 15811132.
View in: PubMed Mentions: 6 Fields:
Translation:HumansAnimalsCells
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
Start with: newest oldestInclude: line numbers double spacing all authors publication IDs